MELANI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 5.363
EU - Europa 3.215
AS - Asia 1.856
SA - Sud America 260
AF - Africa 63
OC - Oceania 38
Totale 10.795
Nazione #
US - Stati Uniti d'America 5.302
RU - Federazione Russa 1.071
SG - Singapore 573
PL - Polonia 557
IT - Italia 548
CN - Cina 407
HK - Hong Kong 303
IE - Irlanda 244
SE - Svezia 231
BR - Brasile 211
VN - Vietnam 208
KR - Corea 139
DE - Germania 128
UA - Ucraina 111
FI - Finlandia 91
FR - Francia 90
GB - Regno Unito 80
IN - India 52
AU - Australia 38
CA - Canada 38
JP - Giappone 37
TR - Turchia 36
JO - Giordania 21
CI - Costa d'Avorio 18
AR - Argentina 17
BD - Bangladesh 17
AT - Austria 15
ID - Indonesia 13
IQ - Iraq 13
NL - Olanda 12
BE - Belgio 11
MX - Messico 11
KE - Kenya 9
PY - Paraguay 8
ZA - Sudafrica 7
CO - Colombia 6
CR - Costa Rica 6
ES - Italia 6
MA - Marocco 6
NG - Nigeria 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
PK - Pakistan 5
SC - Seychelles 5
VE - Venezuela 5
EG - Egitto 4
LT - Lituania 4
SA - Arabia Saudita 4
AL - Albania 3
PE - Perù 3
PH - Filippine 3
AZ - Azerbaigian 2
BH - Bahrain 2
CL - Cile 2
DZ - Algeria 2
JM - Giamaica 2
KG - Kirghizistan 2
MM - Myanmar 2
OM - Oman 2
SV - El Salvador 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CY - Cipro 1
GY - Guiana 1
IL - Israele 1
IR - Iran 1
KZ - Kazakistan 1
LB - Libano 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SN - Senegal 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
Totale 10.795
Città #
Santa Clara 1.164
Ashburn 570
Warsaw 555
Singapore 411
Fairfield 407
Chandler 285
Dublin 245
Hong Kong 244
Woodbridge 216
Wilmington 174
Cambridge 169
Seattle 166
Houston 163
Jacksonville 163
Beijing 151
San Jose 143
Seoul 137
Milan 122
Ann Arbor 104
Dallas 103
The Dalles 83
Buffalo 82
Princeton 76
Altamura 74
Lawrence 71
Hanoi 59
Los Angeles 56
Boston 55
Ho Chi Minh City 55
Lauterbourg 53
Boardman 51
Florence 51
Rome 39
Melbourne 38
Tokyo 37
Bremen 27
Hefei 27
Mumbai 27
San Diego 27
New York 24
Kent 23
Paris 22
Moscow 21
Medford 20
Helsinki 19
Shanghai 19
Abidjan 18
Council Bluffs 18
Izmir 18
Munich 18
Norwalk 15
Vienna 15
Dearborn 14
São Paulo 14
Brooklyn 12
Naples 12
Phoenix 12
Toronto 12
Brussels 11
Clifton 11
Falls Church 11
Dong Ket 10
Hillsboro 10
London 10
Orem 10
Yubileyny 10
Brasília 9
Falkenstein 9
Figino 9
Andover 8
Chennai 8
Frankfurt am Main 8
Jakarta 8
Montreal 8
Redondo Beach 8
Auburn Hills 7
Bologna 7
Catania 7
Genoa 7
Haiphong 7
Miano 7
Nairobi 7
Turin 7
Abuja 6
Chicago 6
Da Nang 6
Nanjing 6
Palermo 6
Verona 6
Belo Horizonte 5
Bern 5
Denver 5
Guangzhou 5
Manchester 5
Mexico City 5
Nuremberg 5
Saint Louis 5
San Francisco 5
Stockholm 5
West Jordan 5
Totale 7.311
Nome #
Adenosine A2A Receptors Modulate Acute Injury and Neuroinflammation in Brain Ischemia. 368
The Selective Antagonism of P2X7 and P2Y1 Receptors Prevents Synaptic Failure and Affects Cell Proliferation Induced by Oxygen and Glucose Deprivation in Rat Dentate Gyrus. 324
The neuron-astrocyte-microglia triad in CA3 after chronic cerebral hypoperfusion in the rat: Protective effect of dipyridamole 298
Time-course of protection by the selective A2A receptor antagonist SCH58261 after transient focal cerebral ischemia. 278
A Selective Histamine H4 Receptor Antagonist, JNJ7777120, Is Protective in a Rat Model of Transient Cerebral Ischemia 271
Role of adenosine in oligodendrocyte precursor maturation 251
The neuron-astrocyte-microglia triad in a rat model of chronic cerebral hypoperfusion: Protective effect of dipyridamole 246
Adenosine in the Central Nervous System: Effects on Neurotransmission and Neuroprotection. 227
Adenosine and Oxygen/Glucose Deprivation in the Brain 222
Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow. 210
ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells. 209
Adenosine A2A antagonists are protective in in vivo and in vitro models of brain ischemia. 204
Adenosine is present in rat brain synaptic vesicles. 203
ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia 200
Adenosine extracellular levels in human brain gliomas: an intraoperative microdialysis study. 188
Adenosine A2A receptor antagonism increases nNOS-immunoreactive neurons in the striatum of Huntington transgenic mice 187
Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation. 186
Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats 182
Adenosine extracellular brain concentrations and role of A2A receptors in ischemia 180
Purinergic signalling in brain ischemia 179
Adenosine A2A antagonists are protective in in vivo and in vitro models of brain ischemia. 176
Adenosine A2A receptor antagonism increases neuronal nitric oxide syntase expression in the striatum of huntington transgenic mice 176
Adenosine A2A receptor-selective stimulation reduces signaling pathways involved in the development of intestine ischemia and reperfusion injury 173
Adenosine and Stroke 172
The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat 169
Selective adenosine A2A receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischemia 164
Time-course of the protective effect of selective adenosine A2A receptor agonists and antagonists after brain focal ischemia in the rat 163
The selective A(2A) receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. 160
Effects of intravenous administration of dipyridamole in a rat model of chronic cerebral ischemia 160
P2X(7) receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat 158
The protective effect of adenosine A2A receptor antagonism in cerebral ischemia 156
Role of adenosine A2A receptors in cerebral ischemia 155
Effect of chronic administration of selective adenosine A2A receptor agonists and antagonists on cerebral injury evaluated up to seven days after focal ischemia in the rat 154
ADENOSINE AND MEMORY STORAGE: EFFECT OF A(1) AND A(2) RECEPTOR ANTAGONISTS. 154
A2A receptors in neuroprotection of dopaminergic neurons. 151
Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects. 147
Adenosine as a biomarker of Huntington Disease 147
The role of ATP and adenosine in the brain under normoxic and ischemic conditions. 146
Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats. 145
Adenosine Receptors in Cerebral Ischemia 145
EFFECT OF N-METHYL-D-ASPARTATE ON MOTOR ACTIVITY AND IN VIVO ADENOSINE STRIATAL OUTFLOW IN THE RAT. 144
Effect of adenosine A2A receptor stimulation on GABA release from the striatum of young and aged rats in vivo 143
Selective adenosine A2A receptor agonists and antagonists protect at different times after brain focal ischemia in the rat 142
In vivo amino acid drelease from the striatum of aging rats: adenosine modulation. 139
Adenosine A(2A) antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington's disease. 136
Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake and freely moving rats after middle cerebral artery occlusion. Correlations with neurological deficit and histopathological damage. 134
Striatal A2A adenosine receptors differentially regulate spontaneous and K+-evoked glutamate release in vivo in young and aged rats 133
The selective adenosine A2A receptor agonist CGS 21680 reduces JNK MAPK activation in oligodendrocytes in injured spinal cord 132
CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation. 130
A2A adenosine receptors inhibits glutamate release in vivo from the striatum of aging rats. 126
Differential glutamate-dependent and glutamate-independent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments. 124
Effect of intravenous administration of dipyridamole in a rat model of chronic cerebral ischemia 122
CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis. 122
Striatal outflow adenosine and amino acid following focal cerebral ischemia: correlation with neurological deficit and histological damage. 117
Amino acids, adenosine choline extracellular levels as possible markers in human brain gliomas: an intraoperative microdialysis study. 113
Extracellular levels of taurine in tumoral, peritumoral and normal brain tissue in patients with malignant glioma: An intraoperative microdialysis study 109
Effect of A2A receptor antagonism on the histological damage, neurological deficit and striatal adenosine and aminoacid outflow following middle cerebral artery occlusion in the rat 108
Intraoperative microdialysis in human brain gliomas: amino acids, adenosine and choline extracellular levels. 105
Excitatory aminoacid and GABA release from the rat striatum in vivo: effect of the selctive A2A adenosine receptor agonist CGS 21680. 98
Selective adenosine A(2A) receptor antagonism reduces JNK MAPK activation in oligodendrocytes after cerebral ischaemia 96
Selective adenosine A2A receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma 95
Regulation of A(2A) adenosine receptor expression and functioning following permanent focal ischemia in rat brain 95
The selective adenosine A2A antagonist SCH58261 is protective in a model of focal cerebral ischemia in the rat 94
Correlation between adenosine and amino acid outflow and neuropathological outcome in rat striatum following middle cerebral artery occlusion. 93
Selective adenosine A2A receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischemia. 88
Effect of the selective adenosine A2A receptor antagonist, SCH 58261, in a model of permanent focal cerebral ischemia in the rat. 79
Effect of A2A receptor antagonism on glutamate outflow from the striatum of young and aged rats in vivo. 77
Sex-Dependent Long-Term Neurobehavioral Recovery in Experimental Neonatal Hypoxic-Ischemic Encephalopathy 38
Totale 10.916
Categoria #
all - tutte 29.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022466 17 53 43 19 13 11 18 32 18 14 105 123
2022/20231.226 129 213 45 107 116 213 152 57 137 5 31 21
2023/2024367 20 46 74 18 21 26 11 120 4 6 16 5
2024/20252.984 101 286 206 457 927 490 47 166 106 67 83 48
2025/20263.032 264 405 227 141 424 167 372 174 217 198 68 375
2026/202743 43 0 0 0 0 0 0 0 0 0 0 0
Totale 10.916